Home › Trial NCT04178317
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
- Trial IDNCT04178317
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorAbbVie
- Enrollment14
- Start date2020-04-02
- ConditionsCancer, Chronic Lymphocytic Leukemia (CLL)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.